Elena N. Plakhotina

Elena N. Plakhotina

Auto-generated profile, based on publicly available information

Elena N. Plakhotina

Vidnoye Perinatal Center

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2022 in Annals of Critical Care
Verified
Journal Article
Open access
NKN. B. Kuzina
N. B. Kuzina
EPE. N. Plakhotina
E. N. Plakhotina
AKArtem Kuzovlev
Artem Kuzovlev
TBT. N. Belousova
T. N. Belousova
EBE. V. Bryantsev
E. V. Bryantsev
DKD. V. Kasina
D. V. Kasina
Introduction. Severe preeclampsia in early stages can be detected by isolated thrombocytopenia, which makes it difficult to diagnose it in time and carry out the necessary therapeutic measures. As a rule, the diagnosis of severe preeclampsia can be declared with a detailed clinical and laboratory researches, and it increases the risks for the mother and the embryo. However, if there are no clinical symptoms of preeclampsia except of thrombocytopenia, there is a problem of differential diagnosis between thrombocytopenia, which has the same symptoms as preeclampsia and gestational thrombocytopenia, which is a physiological peculiarity and does not require any medical interventions and restrictions. Nowadays there are no screening methods for differential diagnosis of these conditions. Objectives. To estimate the possibilities of determing the level of neutrophil extracellular traps (NETs) during the differential diagnosis of preeclampsia and gestational thrombocytopenia. Materials and methods. The comparative analysis of the level of NETs was carried out in three groups of pregnant women. Group 1 included patients with severe preeclampsia (n = 45), group 2-patients with gestational thrombocytopenia (n = 44) and group 3 consisted of healthy pregnant women (n = 44). Results. The research revealed significant increase in the level of NETs in the group of patients with preeclampsia (15.26 %,) compared with the groups of healthy patients (7.65 %, p = 0.001) and patients with gestational thrombocytopenia (7.04 %, р = 0.002). There were no significant differences in the level of NETs between the groups of healthy patients and patients with gestational thrombocytopenia. Conclusions. A significant increase of the level of NETs among the patients with severe preeclampsia allows us to consider the method of calculating the level of NETs among patients with thrombocytopenia which can be detected after the 20th week of pregnancy, if there are no other laboratory and clinical signs of preeclampsia as a screening method for early diagnosis of this complication.

22 October 2020 in Russian Sklifosovsky Journal "Emergency Medical Care"
Verified
Journal Article
Open access
PDF file
EPE. N. Plakhotina
E. N. Plakhotina
TBT. N. Belousova
T. N. Belousova
IKI. A. Kulikov
I. A. Kulikov
RLR. V. Latyshev
R. V. Latyshev
KPK. M. Pavlyutina
K. M. Pavlyutina
Placenta accreta (PAS-disorders) is one of the most serious complications of pregnancy, associated with the risk of massive uterine bleeding, massive hemotransfusion and maternal mortality. Peripartum hysterectomy is a common treatment strategy for patients with placenta accreta. Currently, there is a clear trend of changing surgical tactics in favor of organ-saving operations, but there are no studies devoted to anesthesiological support of such operations.The aim of the study is to substantiate an effective and safe method of anaesthesia in organ-saving operations for placenta accreta spectrum disorders.Materia l and methods The study involved 80 patients with a diagnosis of placenta accreta spectrum disorders, confirmed intraoperatively, who underwent organ-saving operations. The patients were randomized depending on the method of anesthesia into 3 groups: general anesthesia, spinal anesthesia with planned conversion to general after fetal extraction and epidural anesthesia with planned conversion to general also after fetal extraction. The comparison of intraoperative hemodynamics, efficiency of tissue perfusion, efficiency of antinociceptive protection at the stages of surgery was performed. A comparative analysis of the volume of blood loss and blood transfusion, time of patients activation in the postoperative period, severity of pain on the first day after surgery, duration of hospital stay before discharge and comparison of the assessment of the newborn according to Apgar score at first and fifth minute after extraction.Conclusion The study shows that the optimal method of anesthesia in organ-saving operations for placenta accreta spectrum disorders is epidural anesthesia with its planned conversion to general anesthesia with an artificial lung ventilation after fetal extraction. Such an approach to anesthesia allows to maintain stable hemodynamic profile with minimal vasopressor support, sufficient heart performance, providing effective tissue perfusion and a high level of antinociceptive protection at the intraoperative stage and reduce the volume of intraoperative blood loss and hemotransfusion. In the current study there were no differences in neonatal outcomes and duration of hospitalization depending on the method of anesthesia. The advantage of epidural anesthesia with its conversion to general anesthesia was earlier activation after surgery and lower intensity of postoperative pain syndrome.

22 June 2019 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
EPE. N. Plakhotina
E. N. Plakhotina
TBT. N. Belousova
T. N. Belousova
IKI. A. Kulikov
I. A. Kulikov
KPK. M. Pavlyutina
K. M. Pavlyutina
RLR. V. Latyshev
R. V. Latyshev
According to the results of systematic reviews of WHO, maternal mortal-ity associated with massive bleeding almost reached 30% and has no tendency to decrease. Among the causes of massive obstetric hemorrhage, the most challenging ones are uterine hypotension and morbidity adherence placenta. Most severe complication for placentation is placenta increta in the uterine wall. Over the past 50 years, the number of cases with morbidity adherence placenta has in-creased tenfold. By all indications, this pathology has taken on the character of an epidemic and is one of the main causes for massive blood loss and blood transfusion, as well as peripartum hysterectomy. For surgical hemostasis in this pathology we apply X-ray vascular methods (temporary balloon occlusion of large vessels, vascular embolization), ligation of the iliac, uterine, ovarian arteries, various versions of distal hemostasis, including the use of uterine turnstiles, intrauterine and vaginal cylinders, compression sutures. However, data confirm-ing the advantage of any specified methods are not enough. The risk of massive bleeding is high while using any of these methods. The article analyzes the blood saving methods existing at the present stage and possibility of these methods usage in obstetrics. Besides, we describe efficacy and safety of their use in massive blood loss, including the surgical treatment of morbidity adherence placenta.

28 December 2019 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
EPE. N. Plakhotina
E. N. Plakhotina
TBT. N. Belousova
T. N. Belousova
NKN. B. Kuzina
N. B. Kuzina
Thrombocytopenia is the second most frequent hematological complica-tion of pregnancy after anemia. Among all thrombocytopenia during pregnancy, the most common is gestational thrombocytopenia. Gestational thrombocytopenia is not accompanied by coagulation disorders, has a minimal risk of bleeding, for both a mother and her fetus. Nevertheless, according to modern concepts, thrombocytopenia is a contraindication for performing obstetric neuroaxial blockades only on the basis of quantitative count of platelets, without taking into account coagulation status. These contraindications are derived from the general surgery and traumatology practice due to the high risk of developing epidural hematoma, but do not take into account the features, including physiological hypercoagulation, of pregnant patients. Refusal of the patient to perform a neuroaxial blockade during delivery on the basis of only counting the number of platelets often leads to an unreasonable increase in the risk / benefit ratio for both the mother and the fetus. Analysis of the research results indicates a change in attitude towards this problem towards a more loyal approach, taking into account the assessment of the coagulative status of a particular patient.

7 April 2022 in Russian Sklifosovsky Journal "Emergency Medical Care"
Verified
Journal Article
Open access
PDF file
EPE. N. Plakhotina
E. N. Plakhotina
TBT. N. Belousova
T. N. Belousova
NKN. B. Kuzina
N. B. Kuzina
AKArtem Kuzovlev
Artem Kuzovlev
EBE. V. Bryantsev
E. V. Bryantsev
Gestational thrombocytopenia (GT) is the most common type of thrombocytopenia during pregnancy. Unlike other types of thrombocytopenia, it is not accompanied by dysfunction of the cellular component of hemostasis. Currently, a quantitative decrease in platelets in GT is a contraindication to neuraxial blockades (NAB), which significantly reduces the quality of care in childbirth.The aim of the study is to determine the possibility of safe use of neuraxial blockades in gestational thrombocytopenia. A retrospective prospective study involved 70 patients who were performed delivery, depending on obstetric indications, either conservatively or surgically. The patients were divided into two groups. The main group (group No. 1) included 35 patients with gestational thrombocytopenia. The comparison group (group No. 2) consisted of 35 patients with a platelet content above 150×109/l. A comparative intergroup analysis of indicators of a general blood test, coagulogram, thromboelastography with a test for functional fibrinogen before childbirth and 2 days after delivery. The change in platelet content and its effect on the coagulation status of patients during pregnancy were retrospectively analyzed. A comparative assessment of the volume of blood loss during childbirth and the early postpartum period and the risk of complications of neuraxial blockade in patients with and without gestational thrombocytopenia was carried out.It was found that during gestational thrombocytopenia in the perinatal period, there is no decrease in coagulation potential, assessed by the results of coagulography and thromboelastography at a platelet level above 49×109/l. The investigated indicators of hemostasis did not have significant intergroup differences during pregnancy and childbirth. In the group of patients with gestational thrombocytopenia, the volume of blood loss during labor and the postpartum period did not differ from the group without thrombocytopenia, regardless of the method of delivery. The median blood loss after vaginal delivery in group 1 was 225 ml, in group 2 – 250 ml, with abdominal delivery – 572 ml and 386 ml – respectively. In this study, no complications of neuraxial blockade were observed in any of the groups.The results obtained suggest that in patients with gestational thrombocytopenia, even with a significant decrease in platelet content, it is possible to perform neuraxial blockades during labor, taking into account the clinical picture and the absence of coagulation disorders confirmed by thromboelastography.

1 January 2022 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
IKI.A. Kulikov
I.A. Kulikov
TBT.N. Belousova
T.N. Belousova
EPE.N. Plakhotina
E.N. Plakhotina
DID.D. Iskakov
D.D. Iskakov
EME.R. Milutina
E.R. Milutina
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка результатов применения различных методик хирургического гемостаза при оперативном родоразрешении беременных со всеми вариантами врастания плаценты (placenta accreta spectrum — PAS) и выбор оптимальной из них. МАТЕРИАЛ И МЕТОДЫ Прооперированы 173 беременные с диагнозом PAS, которым выполняли 3 различных варианта гемостаза и метропластику. В 1-ю группу (n=32) вошли пациентки, которым после кесарева сечения в дне матки проводили перевязку внутренних подвздошных артерий или маточных сосудов. Во 2-й группе (n=31) осуществляли турникетный гемостаз, а в 3-й группе (n=110) дополняли его баллонной тампонадой влагалища. Изучали объем кровопотери и гемотрансфузии, продолжительность операции и госпитализации — Me [25-й перцентиль; 75-й перцентиль], частоту развития осложнений. РЕЗУЛЬТАТЫ Объем кровопотери в 1, 2 и 3-й группах соответственно составил: 4150 [2764; 5349] мл, 1549 [921,5; 2778,5] мл и 994,5 [730; 1688] мл (p=0,0001). Объем гемотрансфузии эритроцитарной массы в 1-й группе составил: 330 [0; 602,5] мл. В 3-й группе переливаний донорской эритроцитарной массы не было (p=0,0001). Объем гемотрансфузии свежезамороженной плазмы в 1-й группе составил 1069,5 [519,5; 1247,5] мл; во 2-й группе свежезамороженная плазма переливалась небольшому числу пациенток: 0 [0; 600] мл, а в 3-й группе донорская свежезамороженная плазма не потребовалась (p<0,0001). Продолжительность пребывания в стационаре в 1-й группе составила 7 [6; 8] сут, во 2-й и 3-й группах— 5 [4,5; 6] и 5 [4; 6] сут соответственно (p<0,001). В 1, 2 и 3-й группах отмечались статистически значимые различия по частоте гистерэктомии — 4 (12,5%), 2 (6,5%) и 0 соответственно (p<0,001) и частоте релапаротомии — 4 (12,5%), 2 (6,5%) и 2 (1,8%) соответственно (p=0,035). ЗАКЛЮЧЕНИЕ Использование метода турникетного гемостаза с дополнительной влагалищной тампонадой при оперативном родоразрешении у беременных с PAS сопровождается статистически значимо меньшим объемом кровопотери и гемотрансфузии, меньшей частотой развития осложнений по сравнению с аналогичными показателями при применении метода изолированной перевязки внутренних подвздошных или маточных артерий.